Swiss president heads for damage-control EU summit

Send a link to a friend  Share

[April 22, 2021]  By Michael Shields

ZURICH (Reuters) - Swiss President Guy Parmelin heads to Brussels on Friday for a summit with European Commission President Ursula von der Leyen over a stalled treaty that threatens to put ties between Switzerland and its biggest trading partner into a deep freeze.

Many Swiss business leaders who are keen on continued smooth access to the EU market want a treaty, but political resistance to the agreement gives Parmelin little leeway to clinch a deal after years of foot-dragging in Bern.

That could leave Parmelin, a member of the eurosceptic Swiss People's Party, the biggest in parliament, in damage-control mode when he meets von der Leyen, who has urged Bern finally to embrace the draft accord negotiated in 2018.



The Swiss cabinet has said it wants clarifications on some open points before endorsing the pact, and officials in Brussels want concrete suggestions from Parmelin, one source familiar with the talks said.

Parmelin said in a weekend newspaper interview he would seek to move the discussion forward without bombast.

[to top of second column]

Guy Parmelin President of the Swiss Confederation attends a news conference on the outbreak of the coronavirus disease (COVID-19) in Bern, Switzerland, March 12, 2021. REUTERS/Denis Balibouse

"I am not going to play Boris Johnson," he said, referring to the British leader's blustering stance toward EU ties during Britain's exit from the bloc.

The treaty would have non-EU member Switzerland routinely adopt single market rules and provide a more effective way to resolve disputes. Critics say it infringes Swiss sovereignty so much that it would never survive a binding referendum. [L8N2MD5I1]

Failure to strike a deal would leave in place a patchwork of sectoral accords that govern bilateral ties, but block Switzerland from any new access to the single market, dashing plans for an electricity union, for example.

Even the existing accords will erode over time. A deal that eases cross-border trade in medical technology products lapses in May, for instance, and Swiss scientists worry they may be frozen out of the EU's Horizon research programme.

(Reporting by Michael Shields; Editing by Angus MacSwan)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.

Back to top